University of Texas Medical Branch, Galveston, TX, U.S.A.
Works
- From the Editor: Please Come to Boston
- Braeburn Pharmaceuticals and Camurus Expand Collaboration and License Agreement to Include New Combination Product for Pain and Nausea
- Wallace K. Reams, Former President of Aveva Drug Delivery Systems, Joins Transdermal Delivery Solutions Board of Advisors
- Crescita Therapeutics™ Inc. Announces Acquisition of INTEGA Skin Sciences
- Caisson Biotech Seeks Buyer for HEPtune® Drug-Delivery Platform
- NLS Pharma Announces Start of Its Phase 2 Trial for Mazindol in Adult ADHD Patients
- Egalet Announces Scientific Presentations at PAINWeek 2016 Meeting
- Nemaura Pharma Limited Awarded the Prestigious 2016 Frost & Sullivan Award for Best Practices in Enabling Technology Leadership in Transdermal Drug Delivery
- Frost & Sullivan Applauds IFP’s Superior Technology Performance and Best Practices in Providing Tailored, ApplicationSpecific Encapsulated Food Ingredients
- Highland Therapeutics Announces Positive Data from Second Pivotal ADHD Trial for HLD-200
- $1.8 Million Fast-Track NIH SBIR Grant for Manocept™ Immunotherapeutics Evaluation in Kaposi’s Sarcoma Awarded to Navidea
- Nanologica and Alcyone Lifesciences to Collaborate via Licensing Agreement
- NLS Pharma Announces Submission of Investigational New Drug (IND) Application to FDA for Its Controlled-Release Mazindol for the Treatment of Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
